-
Loading metrics
A Phase I Randomized Placebo Controlled Trial of the Safety of 3% SPL7013 Gel (VivaGel®) in Healthy Young Women Administered Twice Daily for 14 Days
- Craig R. Cohen,
- Joelle Brown,
- Anna-Barbara Moscicki,
- Elizabeth A. Bukusi,
- Jeremy R. A. Paull,
- Clare F. Price,
- Stephen Shiboski
x
- Published: January 20, 2011
- https://doi.org/10.1371/journal.pone.0016258
Viewed
Cited
Discussed
Powered by Altmetric
Questions or concerns about usage data? Please let us know.
Saved